Tinlarebant (a/k/a LBS-008) is Belite Bio's orally administered tablet intended to slow disease progression in patientsaffected with Stargardt Disease (STGD1) and Geographic Atrophy (GA) in advanced Dry Age-related

BLTE

Finance Executives Look For Ways To Diversify Cash Strategies After Silicon Valley Bank’s Fallout

By Vandana Singh

March 16, 12:38 PM

Financial officers at companies with money held at Silicon Valley Bank (NASDAQ: SIVB) are re-evaluating their cash-management strategies.

CCLD

News

Panasonic Automotive & Fisker Announce Collaboration To Launch Fisker Pulse Premium Audio System Crafted Exclusively For All-Electric Fisker Ocean SUV

By Benzinga Newsdesk

November 17, 12:51 PM

Panasonic Automotive's award-winning ELS STUDIO 3D® PREMIUM AUDIO Reimagined for the Fisker Ocean Blends Best-in-Class Audio Performance with Sustainability-focused DesignLOS ANGELES, Nov. 17, 2023 /PRNewswire/ --

FSR

Maxim Group Downgrades Pulse Biosciences to Hold

Related Posts

RBC Capital Maintains Outperform on nVent Electric, Raises Price Target to $41

Belite Bio Receives Approval To Initiate Tinlarebant Phase 3 Clinical Trial For Ga In Australia

Finance Executives Look For Ways To Diversify Cash Strategies After Silicon Valley Bank’s Fallout

Panasonic Automotive & Fisker Announce Collaboration To Launch Fisker Pulse Premium Audio System Crafted Exclusively For All-Electric Fisker Ocean SUV